ask="2.85"
ask_size="1000"
average_daily_volume="941864"
bid="2.70"
bid_size="1000"
book_value="0.34"
change="+0.04"
change_from_200_day_moving_average="1.16"
change_from_50_day_moving_average="1.08"
change_from_52_week_high="-2.25"
change_From_52_week_low="1.74"
change_in_percent="+1.42%"
close="2.85"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.49"
ebitda="-12.32M"
eps_estimate_current_year="-1.58"
eps_estimate_next_quarter="-0.36"
eps_estimate_next_year="-0.88"
ex_dividend_date="N/A"
float_shares="4532000"
high="2.85"
high_52_weeks="5.10"
last_trade_date="2/24/2017"
last_trade_price="2.85"
last_trade_size="71050"
last_trade_time="4:00pm"
low="2.41"
low_52_weeks="1.11"
market_capitalization="27.32M"
moving_average_200_day="1.69"
moving_average_50_day="1.77"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.00"
open="2.62"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+68.75%"
percent_change_from_50_day_moving_average="+60.93%"
percent_change_from_52_week_high="-44.12%"
percent_change_from_52_week_low="+156.76%"
previous_close="2.81"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="8.29"
price_per_sales="52.93"
revenue="508889.00"
shares_outstanding="9585000"
short_ratio="0.76"
stock_exchange="NCM"
symbol="EYEG"
volume="1601401"
weeks_range_52="1.11 - 5.10"
